XL Axiata Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? XL Axiata Tbk. trades at Rp2,550 (market cap 46.05T, 3.6M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: XL Axiata Tbk. is far larger — about 275.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and XL Axiata Tbk. is more actively traded (3.6M versus 71K). Which is the better fit depends on your goals.
| EXCL | OBAT | |
|---|---|---|
Market Cap | 46.05T | 167.37B |
Volume | 3.6M | 71K |
Lot | 35.96K | 710 |
Turnover | 9.04B | 17.51M |
Average Price | 2,513.7 | 246.63 |
Value | 9.04B | 17.51M |
Indicative Equilibrium Price | 2,550 | 246 |
Indicative Equilibrium Volume | 977 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT XL Axiata Tbk (the Company) which was previously known as PT Excelcomindo Pratama Tbk, was initially established under the name PT Grahametropolitan Lestari. The Company was established on Oct 6th, 1989.The articles of association have been amended several times, most recently on Aug 2, 2005, concerning among other the change of par value, equity and public offering. The company started its operation since October 1996 and was the 3rd biggest company in Indonesia for the number of customer and income.
Read more on EXCL →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →